Turkish Journal of Medical Sciences
Volume 43

Number 2

Article 9

1-1-2013

Dexmedetomidine infusion prevents postoperative shivering in
patients undergoing gynecologic laparoscopic surgery
SEMRA KARAMAN
İLKBEN GÜNÜŞEN
MUSTAFA ARDA CEYLAN
YÜCEL KARAMAN
ESRA NUR ÇETİN

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
KARAMAN, SEMRA; GÜNÜŞEN, İLKBEN; CEYLAN, MUSTAFA ARDA; KARAMAN, YÜCEL; ÇETİN, ESRA NUR;
DERBENT, ABDURRAHİM; and ERGENOĞLU, AHMET METE (2013) "Dexmedetomidine infusion prevents
postoperative shivering in patients undergoing gynecologic laparoscopic surgery," Turkish Journal of
Medical Sciences: Vol. 43: No. 2, Article 9. https://doi.org/10.3906/sag-1204-80
Available at: https://journals.tubitak.gov.tr/medical/vol43/iss2/9

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Dexmedetomidine infusion prevents postoperative shivering in patients
undergoing gynecologic laparoscopic surgery
Authors
SEMRA KARAMAN, İLKBEN GÜNÜŞEN, MUSTAFA ARDA CEYLAN, YÜCEL KARAMAN, ESRA NUR ÇETİN,
ABDURRAHİM DERBENT, and AHMET METE ERGENOĞLU

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol43/iss2/9

Turkish Journal of Medical Sciences

Turk J Med Sci
(2013) 43: 232-237
© TÜBİTAK
doi:10.3906/sag-1204-80

http://journals.tubitak.gov.tr/medical/

Research Article

Dexmedetomidine infusion prevents postoperative shivering in patients
undergoing gynecologic laparoscopic surgery
1,

1

1

2

Semra KARAMAN *, İlkben GÜNÜŞEN , Mustafa Arda CEYLAN , Yücel KARAMAN ,
1
1
3
Esra Nur ÇETİN , Abdurrahim DERBENT , Ahmet Mete ERGENOĞLU
1
Department of Anesthesiology and Reanimation, Faculty of Medicine, Ege University, İzmir, Turkey
2
Department of Anesthesiology and Reanimation, Tepecik Teaching Hospital, İzmir, Turkey
3
Department of Obstetrics and Gynecology, Faculty of Medicine, Ege University, İzmir, Turkey
Received: 17.04.2012

Accepted: 18.07.2012

Published Online: 15.03.2013

Printed: 15.04.2013

Aim: This placebo-controlled, randomized study was performed to evaluate the efficacy of dexmedetomidine in preventing postoperative
shivering.
Materials and methods: Sixty patients undergoing gynecologic laparoscopic surgery were assigned randomly to 2 groups to be
administered either dexmedetomidine as a loading of 1 µg kg–1 for 10 min followed by a maintenance infusion of 0.5 µg kg–1 h–1 (Group
D, n = 30), or a normal saline infusion (Group S, n = 30).
Results: Postoperative shivering was observed in 14 patients in Group S and in 3 patients in Group D (P = 0.001). The sedation scores
were higher in the dexmedetomidine group than in the saline group (P < 0.05). Postoperative pain scores were higher in the saline group
for the first 40 min (P < 0.05). Perioperative tympanic temperatures were not different between the groups.
Conclusion: Intraoperative dexmedetomidine infusion reduces postoperative shivering in patients undergoing gynecologic laparoscopy.
Key words: Dexmedetomidine, gynecologic laparoscopy, postoperative shivering

1. Introduction
Postoperative shivering occurs in up to 60% of patients
recovering from general anesthesia (1). Patients report that
shivering is remarkably uncomfortable, and some even
find the accompanying cold sensation worse than surgical
pain. Moreover, shivering may aggravate postoperative
pain simply by stretching surgical incisions. Shivering also
occasionally impedes monitoring techniques and increases
intraocular and intracranial pressures (2).
As shivering is a response to hypothermia, body
temperature should normally be maintained within the
range of 36.5–37.5 °C (3). A major factor contributing
to intraoperative hypothermia is radiant heat loss from
the exposure of skin surfaces and abdominal viscera
to the ambient environment. Other factors include the
use of ambient irrigation solution in the peritoneal
cavity, ambient intravenous (IV) fluid, and ventilation
with dry anesthetic gases. The mechanism of heat loss
during laparoscopy is different from that during open
surgery. Laparoscopic operations eliminate the exposure
of abdominal viscera to the ambient environment but
* Correspondence: semra.karaman@ege.edu.tr
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expose the peritoneal surface to large volumes of ambient
CO2 gas during pneumoperitoneum (4,5). Thus, patients
undergoing laparoscopy in particular are at risk of
intraoperative hypothermia.
Various drugs, including pethidine, other opioids
(alfentanil, pentazocine, fentanyl, sufentanil, or
buprenorphine), doxapram, clonidine, and ketanserin,
have all been reported to be effective in suppressing
postoperative shivering (6,7). Although many drugs are
used to treat postoperative shivering, the search for an
ideal drug is still ongoing.
Dexmedetomidine, an alpha-2 agonist, is a new drug
used for analgesia and sedation either in perioperative
settings or in intensive care units (8,9). In previous studies,
a prophylactic single dose of dexmedetomidine was
generally found to be effective for shivering, but there are a
few studies demonstrating the effect of dexmedetomidine
via infusion in the intraoperative period on shivering after
gynecologic laparoscopy (10,11).
The aim of this placebo-controlled, randomized
study was to evaluate the efficacy of intraoperative
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dexmedetomidine infusion on postoperative shivering
after gynecologic laparoscopy under general anesthesia.
2. Materials and methods
This prospective, randomized, double-blind, placebocontrolled study was approved by the local ethics
committee. Informed consent was obtained from
all patients. Sixty patients with American Society of
Anesthesiologists (ASA) physical status I or II, between the
ages of 20 to 50 years and undergoing elective gynecologic
laparoscopy, were included in the study. Patients with
hyperthyroidism, cardiopulmonary or respiratory disease,
a psychological disorder, or an initial body temperature of
>37.5 °C or <36.5 °C were excluded from the study.
None of the patients were premedicated. In both
groups, general anesthesia was induced with propofol
2.5 mg kg–1 and fentanyl 1 µg kg–1, followed by the
administration of rocuronium (0.6 mg kg–1) to facilitate
endotracheal intubation. General anesthesia was then
maintained with sevoflurane (2 ± 0.5% end-tidal oxygen)
in a 50% air–oxygen mixture. Bispectral index (BIS) values
were maintained between 40 and 60. If a BIS value of
>60 1 µg kg–1 was observed, fentanyl was administered.
Ventilation was mechanically controlled to maintain an
end-tidal carbon dioxide pressure tension of 30–35 mmHg.
The patients were covered with surgical drapes during
anesthesia but were not actively heated. The temperature
of the operating rooms was kept between 20 and 23 °C.
Participants were randomized into 1 of 2 study groups,
using a computer-generated random number table, as
Group D or Group S. After endotracheal intubation,
Group D received a loading dose of dexmedetomidine of
1 µg kg–1 over 10 min, followed by an infusion of 0.5 µg
kg–1 h–1. Group S received the same amount of 0.9% saline
infusion. The drugs were prepared in coded syringes by
an anesthesiologist who was not involved in the anesthetic
or postoperative management of the patient. The infusions
were stopped at the beginning of the closure of the fascia,
and then 1 g of paracetamol (Perfalgan, 100 mL, Bristol
Myers Squibb) and 1 mg kg–1 of tramadol (Grünenthal
GmbH) were administered by IV infusion to all patients.
Tympanic temperatures (Braun®) and hemodynamic
data for all patients were recorded before and after induction
of anesthesia; after intubation; at 15, 30, and 60 min during
the operation; and just before and after extubation (DatexOhmeda®, Helsinki, Finland). The patients who needed
an additional dose of fentanyl, and to whom atropine
or ephedrine were administered intraoperatively due to
bradycardia (<45 bpm) and hypotension, were recorded.
At the end of surgery, residual neuromuscular blockade
was antagonized with IV neostigmine at 0.04 mg kg–1 and
atropine at 0.02 mg kg–1, and the patients were extubated.

Extubation time (from termination of sevoflurane
application until extubation), the duration of anesthesia,
and the duration of surgery were noted.
In the recovery room, all patients received oxygen
via a face mask and were covered with a cotton blanket
and monitored. The shivering, pain, and sedation
scores were assessed by an investigator in charge of the
postanesthesia care unit (PACU) who was not aware of
the administered drug. Postoperative shivering, pain,
and sedation scores were recorded every 10 min during
the first hour. The intensity of postoperative shivering was
graded using a 5-point scale between 0 and 4, similar to
the one validated by Sagir et al. (12): 0 = no shivering; 1
= piloerection, peripheral vasoconstriction but no visible
shivering; 2 = muscular activity in only one muscle group;
3 = muscular activity in more than one muscle group
but not generalized; 4 = shivering involving the whole
body. Postoperative pain was graded on a visual analogue
scale (VAS) with 0 mm = no pain, 100 mm = very severe
pain. Postoperative sedation was graded as: 1 = alert, 2 =
alert but drowsy, 3 = responds to voice, 4 = responds to
gentle tactile stimulation, 5 = responds to vigorous tactile
stimulation, 6 = not able to be aroused (10). The patients
who had a pain score of greater than 40 mm received 1 mg
kg–1 of intramuscular diclofenac sodium, and the patients
with shivering grades of more than 2 received 0.5 mg kg–1
of IV meperidine.
2.1. Statistical analysis
Statistical analysis was performed using SPSS 15.0 (SPSS
Inc., Chicago, IL). The incidence of postanesthetic
shivering was used as the main end-point for statistical
analysis. Based on previously published data (10), a sample
size of 27 patients per group was sufficient to detect a
reduction in postoperative shivering of at least 30% when
compared with the control by using Fisher’s exact test with
an α risk set at 5% and the β risk at 20%.
Results were expressed with an absolute number (n),
a percentage (%), or mean ± standard deviation (SD).
Differences in age, body weight, duration of surgery,
duration of anesthesia, extubation time, and the effects
of treatment in all parameters of the 2 groups (tympanic
temperatures, mean arterial pressures [MAPs], heart rates
[HRs]) were tested using the Student t-test. The frequency
distributions of ASA physical status; fentanyl, ephedrine,
and atropine administration; shivering and the severity of
shivering; degree of sedation; and drug side effects were
tested statistically using the chi-square test and Mann–
Whitney U test. Data within groups were analyzed using
repeated-measures analysis of variance followed by post
hoc Bonferroni correction testing. A P-value of less than
0.05 was considered to be significant.
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3. Results
Patient characteristics, duration of surgery, and anesthesia
were similar in both groups (Table 1).
Extubation time was longer in the dexmedetomidine
group than in the placebo group (P < 0.05). There were
significant differences within the groups regarding
intraoperative hemodynamic parameters when compared
with the preoperative values. Hypotension developed in
2 patients in Group D but in none in the placebo group.
These patients were successfully treated with 5 mg of
ephedrine. MAPs were lower in the dexmedetomidine
group, especially after induction of anesthesia, at 60
min, and before extubation. Mean HRs were lower in
the dexmedetomidine group after onset of the infusion
at all measuring times except for 15 min. Significantly
more patients in the dexmedetomidine group needed
atropine to treat intraoperative bradycardia than in the
placebo group (P > 0.05) (Table 1). None of the patients
in the dexmedetomidine group were given fentanyl

during the operation, whereas 5 patients in the placebo
group needed intraoperative fentanyl (Table 1). The total
dexmedetomidine and fentanyl consumption in Group
D was 98.6 ± 20.1 µg and 77.1 ± 28.5 µg, respectively,
while in Group S, fentanyl consumption was 64.5 ± 10.8
µg. Postoperatively, MAP and HR were lower in the
dexmedetomidine group at all measuring times.
The tympanic temperatures of both groups showed a
statistically significant reduction at the end of the operation
when compared with the baseline values (P < 0.05). There
were no statistically significant differences between groups
in the intraoperative and postoperative values (Figure).
Postoperative shivering was observed in 14 patients
in the placebo group (46.6%) and in 3 patients in the
dexmedetomidine group (10%) (P = 0.001). The intensity
of shivering was lower in the dexmedetomidine group than
in the placebo group (P > 0.05), and grade 4 shivering was
not noted in any of the patients in the dexmedetomidine
group (Table 2).

Table 1. Patient characteristics and perioperative data (mean ± SD, n, %).
Group S
(n = 30)

Group D
(n = 30)

Age (years)

31.9 ± 4.7

32.33 ± 6.2

Weight (kg)

65.87 ± 9.9

64.5 ± 10.86

ASA grade (I / II)

19 / 11

21 / 9

Duration of surgery (min)

65.83 ± 11.75

62.33 ± 19.90

Duration of anesthesia (min)

74.67 ± 11.13

71.17 ± 18.36

5.2 ± 1.34

7.63 ± 1.62*

Operation room temperature (°C)

21.63 ± 1.03

21.93 ± 1.18

PACU temperature (°C)

24.97 ± 0.89

24.6 ± 0.81

5 / 16.6

11 / 36.6

0

2 / 6.6

5 / 16.6

0

Extubation time (min)

Patient receiving atropine (n) / %
Patient receiving ephedrine (n) / %
Patient receiving fentanyl (n) / %

Saline group
Dexmedetomidine group

36.6
36.2

*
*

*

35.8

*

*

35.4

*

*

60
m
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*
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* P < 0.05 (between the groups).

Figure. Mean intraoperative (left) and postoperative (right) tympanic temperatures. *P < 0.05 compared to baseline values
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Table 2. Postoperative shivering scores [median (minimum–maximum)].
Time
(min)

Group S
(n = 30)

Group D
(n = 30)

0

1.5 (0–4)

0 (0–3)*

10

1.5 (0–4)

0 (0–3)*

20

1 (0–4)

0 (0–3)*

30

0.5 (0–4)

0 (0–3)*

40

0 (0–2)

0 (0–2)

50

0 (0–2)

0 (0–2)

60

0 (0–0)

0 (0–0)

*P < 0.05 (between the groups).

Sedation scores were lower than 3 in all patients.
However, sedation scores were significantly higher at all
times in the dexmedetomidine group than in the placebo
group (P < 0.05) (Table 3).
Pain scores were higher in the saline group during the
first 40 min (P < 0.05). Moreover, the time to first analgesic
requirement was shorter in the placebo group (10.3 ± 5.7
vs. 37.8 ± 5.7 min; P < 0.05).
4. Discussion
In the present study, 14 of 30 patients (46.6%) in the placebo
group suffered from postoperative shivering. We found that
intraoperative infusion of dexmedetomidine significantly
reduced the frequency and severity of postanesthetic
shivering with respect to placebo in patients undergoing
gynecologic laparoscopy under general anesthesia.

The α2-receptor agonists can also be used for shivering.
They are effective in treating established postanesthetic
shivering and exert their effects by vasoconstriction and
reducing the thresholds for shivering (13).
Core hypothermia and vasoconstriction often occur
before postanesthetic shivering, although that is not
always the case. Furthermore, intraoperative hypothermia
is a common event during laparoscopic surgery because
the contact of carbon dioxide (CO2), which is usually
delivered at room temperature (20
–21 °C) and at
relatively low humidity, with the peritoneal surface can
cause hypothermia (12,14,15). The risk of intraoperative
hypothermia is increased especially when the duration of
the laparoscopic operation is long (>3 h), resulting from
the higher volume of CO2 instilled during the procedure.
Similar to the study done by Elvan et al. (11), baseline

Table 3. Postoperative sedations scores [median (minimum–maximum)].
Time
(min)

Group S
(n = 30)

Group D
(n = 30)

0

1 (0–2)

2 (0–2)*

10

1 (0–2)

2 (0–2)*

20

1 (0–2)

1 (0–2)*

30

0 (0–2)

1 (0–2)*

40

0 (0–2)

1 (0–2)*

50

0 (0–2)

1 (0–2)*

60

0 (0–2)

0 (0–2)

* P < 0.05 (between the groups).
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core temperature in the present study began to decrease
after 10 min, reaching a drop of 1.3° C below the baseline
temperature at 60 min. However, there were no statistically
significant differences between the groups. In the
postoperative period, temperatures started to rise toward
baseline values, but the difference between the groups did
not reach the level of significance. Postanesthetic shivering
could be induced by mild perioperative hypothermia.
Tramadol has been found to be effective in treating
postanesthetic shivering (16). According to core
temperature measurements, only 20% of the patients in
the dexmedetomidine group experienced postanesthetic
shivering after an abdominal hysterectomy when
dexmedetomidine was infused at a rate of 0.4 µg kg–1 h–1 (10).
In the present study, we found 10% lower postanesthetic
shivering in the dexmedetomidine group. We attributed
this difference to tramadol being administered at the
end of surgery for postoperative analgesia and, possibly,
to tramadol and dexmedetomidine acting synergically
(17). In our study, tympanic temperature measurements
were comparable between the 2 groups, while Elvan et
al. (11) found them to be lower in dexmedetomidine
groups. Those authors attributed this to dexmedetomidine
reducing the core temperature. Differences in the types of
surgical procedures and postoperative analgesia could also
be the sources of discrepancies in results.
Similar to findings of other studies in the literature,
dexmedetomidine alone caused negligible sedation and
did not depress respiration markedly (18). Respiratory
depression was not encountered in any of the patients while
in the recovery room, although extubation time was longer
in the dexmedetomidine group. Even though the sedative
effects of dexmedetomidine might have contributed to the
alleviation of shivering, we believe that the proven effect of
dexmedetomidine in the prevention of shivering is by the
reducing of vasoconstriction and the shivering threshold
centrally.
Horn et al. (19) argued that nonthermoregulatory
shivering was facilitated by postoperative surgical pain.
Numerous researchers demonstrated the analgesic
effects of dexmedetomidine. The analgesic effect of
dexmedetomidine appears to be mediated by both

supraspinal and spinal mechanisms, with the α2adrenoceptors in the locus ceruleus (a supraspinal site)
and dorsal horn of the spinal cord being involved in this
activity (20,21). Sitilci et al. (22) argued that patients could
achieve better postoperative comfort and the need for
tramadol would be lower if dexmedetomidine was infused
continuously during a surgical procedure. Similarly, in
a placebo-controlled trial, Venn et al. (23) reported that
dexmedetomidine decreased the need for rescue sedation
and analgesia significantly for up to 24 h after the operation.
Gurbet et al. (20) reported that effective postoperative
analgesia and reduction in requirement for postoperative
morphine with consequent reduction in the incidence
of adverse effects could be achieved by continuous IV
administration of dexmedetomidine during abdominal
surgery. In the present study, significantly higher VAS
scores in the dexmedetomidine group were found than in
the placebo group within the first 40 min, associated with
the high frequency of shivering in the placebo group.
Compared to the placebo group, MAP and HR values
measured during and after the surgery were significantly
lower in the dexmedetomidine group, and these
hemodynamic findings were reported in other studies, as
well (20,24). Use of α2-receptor agonists for prevention
of postanesthesia shivering can be complicated by their
principal pharmacological effects, namely hypotension
and bradycardia (25), but none of the patients who received
dexmedetomidine in the present study experienced
clinically significant bradycardia or required correction of
hemodynamics.
In conclusion, the results of this study indicated that
intraoperative dexmedetomidine infusion rendered a
significant reduction in the frequency and severity of
postanesthetic shivering while causing minimal sedation.
Intraoperative dexmedetomidine infusion, especially
during laparoscopic procedures, is an alternative worth
considering in alleviation of postoperative shivering, as
well as in analgesia and sedation.
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